Sage Therapeutic Com (SAGE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2025 | 03-2025 | 12-2024 | 09-2024 | 06-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -111,866 | -62,214 | -400,666 | -304,888 | -211,337 |
| Depreciation Amortization | -1,207 | -869 | -5,450 | -4,636 | -2,844 |
| Accounts receivable | -8,105 | N/A | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | -12,007 | -7,264 | 2,381 | -3,192 | -1,668 |
| Other Working Capital | -42,710 | -25,435 | 84,762 | 64,004 | 65,182 |
| Other Operating Activity | 35,477 | 14,054 | 51,779 | 48,078 | 32,398 |
| Operating Cash Flow | $-140,418 | $-81,728 | $-267,194 | $-200,634 | $-118,269 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 126,801 | 45,783 | 266,678 | 220,104 | 139,050 |
| Investing Cash Flow | $126,801 | $45,783 | $266,678 | $220,104 | $139,050 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 242 | 242 | 11,183 | 11,184 | 9,748 |
| Other Financing Activity | -159 | -94 | -520 | -519 | -120 |
| Financing Cash Flow | $83 | $148 | $10,663 | $10,665 | $9,628 |
| Beginning Cash Position | 82,471 | 82,471 | 72,324 | 72,324 | 72,324 |
| End Cash Position | 68,937 | 46,674 | 82,471 | 102,459 | 102,733 |
| Net Cash Flow | $-13,534 | $-35,797 | $10,147 | $30,135 | $30,409 |
| Free Cash Flow | |||||
| Operating Cash Flow | -140,418 | -81,728 | -267,194 | -200,634 | -118,269 |
| Free Cash Flow | -140,418 | -81,728 | -267,194 | -200,634 | -118,269 |